Stem Cell Research Innovation for Women
The innovative C’elle service provides women with the exclusive opportunity to build their own personal healthcare and wellness investment portfolio comprised of precious menstrual stem cells that are highly prolific and have demonstrated capability to differentiate into many other types of stem cells such as cardiac, neural, bone, fat and cartilage. Today, you now have the ability to preserve your very own priceless portfolio of stem cells that may serve as the basis for many different customized regenerative therapies that may emerge over time to treat yourself or possibly even a member of your own family for a potential host of life-affecting diseases.
Whatever your age, it is natural to feel as though you may live forever and also to believe that you will likely have plenty of time in the future to preserve your C’elle menstrual stem cells. So what’s the rush? Why take measures to subscribe to this progressive and cutting edge service today? With the passing of each month our body ages and this aging process will inevitably impact the quality and quantity of stem cells produced over time. C’elle menstrual stem cells may provide you and possibly even your loved ones with a potentially invaluable resource for healthcare and wellness therapies in the future. The landmark discovery of C’elle menstrual stem cells is seismic in many ways because this is the first time that highly prolific and multipotent (able to differentiate into other cell types) adult stem cells have been harvested in such a painless, non-invasive and affordable manner as compared to other stem cell sources such as bone marrow, fat or adult peripheral blood that already have established histories of success in adult stem transplants.
Check out this page to see C’elle Client Testimonial, if you want to know more details, please visit C’elle Stem Cell Research Innovation.
Related posts
Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically to your feed reader.
Comments
No comments yet.
Leave a comment